Lineage Cell Therapeutics, Inc.LCTXNYSE
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 1 | 4↑404.0% | 15↑277.4% | 9↓39.2% | 9↑6.2% |
| Gross Profit | 0 | 2↑536.6% | 14↑465.8% | 8↓40.8% | 9↑10.8% |
| Operating Income | -26 | -49↓86.1% | -23↑54.2% | -25↓9.8% | -21↑13.2% |
| Net Income | -21 | -43↓108.3% | -26↑38.9% | -21↑18.2% | -19↑13.4% |
| EBITDA | -24 | -48↓98.0% | -22↑54.9% | -24↓10.3% | -21↑13.2% |
| EPS Diluted | -0.14 | -0.26↓85.7% | -0.15↑42.3% | -0.12↑20.0% | -0.09↑22.5% |